Literature DB >> 26538564

BAG2 Gene-mediated Regulation of PINK1 Protein Is Critical for Mitochondrial Translocation of PARKIN and Neuronal Survival.

Dianbo Qu1, Ali Hage1, Katie Don-Carolis1, En Huang1, Alvin Joselin1, Farzaneh Safarpour1, Paul C Marcogliese1, Maxime W C Rousseaux1, Sarah J Hewitt1, Tianwen Huang1, Doo-Soon Im1, Steve Callaghan1, Danielle Dewar-Darch2, Daniel Figeys2, Ruth S Slack1, David S Park3.   

Abstract

Emerging evidence has demonstrated a growing genetic component in Parkinson disease (PD). For instance, loss-of-function mutations in PINK1 or PARKIN can cause autosomal recessive PD. Recently, PINK1 and PARKIN have been implicated in the same signaling pathway to regulate mitochondrial clearance through recruitment of PARKIN by stabilization of PINK1 on the outer membrane of depolarized mitochondria. The precise mechanisms that govern this process remain enigmatic. In this study, we identify Bcl2-associated athanogene 2 (BAG2) as a factor that promotes mitophagy. BAG2 inhibits PINK1 degradation by blocking the ubiquitination pathway. Stabilization of PINK1 by BAG2 triggers PARKIN-mediated mitophagy and protects neurons against 1-methyl-4-phenylpyridinium-induced oxidative stress in an in vitro cell model of PD. Collectively, our findings support the notion that BAG2 is an upstream regulator of the PINK1/PARKIN signaling pathway.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Parkinson disease; cell death; neurodegenerative disease; translocation; ubiquitylation (ubiquitination)

Mesh:

Substances:

Year:  2015        PMID: 26538564      PMCID: PMC4683266          DOI: 10.1074/jbc.M115.677815

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Pink1 kinase and its membrane potential (Deltaψ)-dependent cleavage product both localize to outer mitochondrial membrane by unique targeting mode.

Authors:  Dorothea Becker; Judith Richter; Maja A Tocilescu; Serge Przedborski; Wolfgang Voos
Journal:  J Biol Chem       Date:  2012-04-30       Impact factor: 5.157

2.  Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.

Authors:  Yufeng Yang; Stephan Gehrke; Yuzuru Imai; Zhinong Huang; Yingshi Ouyang; Ji-Wu Wang; Lichuan Yang; M Flint Beal; Hannes Vogel; Bingwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

3.  Parkin-induced mitophagy in the pathogenesis of Parkinson disease.

Authors:  Derek Narendra; Atsushi Tanaka; Der-Fen Suen; Richard J Youle
Journal:  Autophagy       Date:  2009-07-22       Impact factor: 16.016

4.  ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons.

Authors:  Alvin P Joselin; Sarah J Hewitt; Steve M Callaghan; Raymond H Kim; Young-Hwa Chung; Tak W Mak; Jie Shen; Ruth S Slack; David S Park
Journal:  Hum Mol Genet       Date:  2012-08-07       Impact factor: 6.150

5.  PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria.

Authors:  Yun Chen; Gerald W Dorn
Journal:  Science       Date:  2013-04-26       Impact factor: 47.728

6.  Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1.

Authors:  Andreas Weihofen; Beth Ostaszewski; Yasufumi Minami; Dennis J Selkoe
Journal:  Hum Mol Genet       Date:  2007-11-14       Impact factor: 6.150

7.  Cytoplasmic localization and proteasomal degradation of N-terminally cleaved form of PINK1.

Authors:  Sho Takatori; Genta Ito; Takeshi Iwatsubo
Journal:  Neurosci Lett       Date:  2007-11-26       Impact factor: 3.046

8.  Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.

Authors:  Tohru Kitada; Antonio Pisani; Douglas R Porter; Hiroo Yamaguchi; Anne Tscherter; Giuseppina Martella; Paola Bonsi; Chen Zhang; Emmanuel N Pothos; Jie Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

9.  Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease.

Authors:  Dianbo Qu; Juliet Rashidian; Matthew P Mount; Hossein Aleyasin; Mohammad Parsanejad; Arman Lira; Emdadul Haque; Yi Zhang; Steve Callaghan; Mireille Daigle; Maxime W C Rousseaux; Ruth S Slack; Paul R Albert; Inez Vincent; John M Woulfe; David S Park
Journal:  Neuron       Date:  2007-07-05       Impact factor: 17.173

10.  The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy.

Authors:  Victoria S Burchell; David E Nelson; Alvaro Sanchez-Martinez; Marta Delgado-Camprubi; Rachael M Ivatt; Joe H Pogson; Suzanne J Randle; Selina Wray; Patrick A Lewis; Henry Houlden; Andrey Y Abramov; John Hardy; Nicholas W Wood; Alexander J Whitworth; Heike Laman; Helene Plun-Favreau
Journal:  Nat Neurosci       Date:  2013-08-11       Impact factor: 24.884

View more
  24 in total

1.  Mitochondria in neurodegeneration.

Authors:  Charleen T Chu
Journal:  Curr Opin Physiol       Date:  2022-04-01

2.  PINK1: Multiple mechanisms of neuroprotection.

Authors:  Britney N Lizama; P Anthony Otero; Charleen T Chu
Journal:  Int Rev Mov Disord       Date:  2021-10-04

3.  BAG2 prevents Tau hyperphosphorylation and increases p62/SQSTM1 in cell models of neurodegeneration.

Authors:  Raquel S Lima; Daniel C Carrettiero; Merari F R Ferrari
Journal:  Mol Biol Rep       Date:  2022-05-25       Impact factor: 2.742

4.  Chronic treatment with the complex I inhibitor MPP+ depletes endogenous PTEN-induced kinase 1 (PINK1) via up-regulation of Bcl-2-associated athanogene 6 (BAG6).

Authors:  Manish Verma; Jianhui Zhu; Kent Z Q Wang; Charleen T Chu
Journal:  J Biol Chem       Date:  2020-04-24       Impact factor: 5.157

Review 5.  Neuroinflammation & pre-mature aging in the context of chronic HIV infection and drug abuse: Role of dysregulated autophagy.

Authors:  Ming-Lei Guo; Shilpa Buch
Journal:  Brain Res       Date:  2019-09-12       Impact factor: 3.252

6.  PINK1-mediated phosphorylation of LETM1 regulates mitochondrial calcium transport and protects neurons against mitochondrial stress.

Authors:  En Huang; Dianbo Qu; Tianwen Huang; Nicoletta Rizzi; Wassamon Boonying; Dorothy Krolak; Paolo Ciana; John Woulfe; Christine Klein; Ruth S Slack; Daniel Figeys; David S Park
Journal:  Nat Commun       Date:  2017-11-09       Impact factor: 14.919

Review 7.  BAG2 structure, function and involvement in disease.

Authors:  Lixia Qin; Jifeng Guo; Qian Zheng; Hainan Zhang
Journal:  Cell Mol Biol Lett       Date:  2016-09-20       Impact factor: 5.787

Review 8.  Chaperone-Based Therapies for Disease Modification in Parkinson's Disease.

Authors:  Erik L Friesen; Mitch L De Snoo; Luckshi Rajendran; Lorraine V Kalia; Suneil K Kalia
Journal:  Parkinsons Dis       Date:  2017-08-21

Review 9.  The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?

Authors:  Tianfang Jiang; Gen Li; Jun Xu; Shane Gao; Xu Chen
Journal:  Front Immunol       Date:  2018-09-27       Impact factor: 7.561

10.  Nuclear receptor/Wnt beta-catenin interactions are regulated via differential CBP/p300 coactivator usage.

Authors:  Masaya Ono; Keane K Y Lai; Kaijin Wu; Cu Nguyen; David P Lin; Ramachandran Murali; Michael Kahn
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.